These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15169706)

  • 1. Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.
    Martin A; Scahill L; Anderson GM; Aman M; Arnold LE; McCracken J; McDougle CJ; Tierney E; Chuang S; Vitiello B
    Am J Psychiatry; 2004 Jun; 161(6):1125-7. PubMed ID: 15169706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.
    Hellings JA; Zarcone JR; Crandall K; Wallace D; Schroeder SR
    J Child Adolesc Psychopharmacol; 2001; 11(3):229-38. PubMed ID: 11642473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone-associated weight gain in children and adolescents: a retrospective chart review.
    Martin A; Landau J; Leebens P; Ulizio K; Cicchetti D; Scahill L; Leckman JF
    J Child Adolesc Psychopharmacol; 2000; 10(4):259-68. PubMed ID: 11191686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment.
    Maayan LA; Vakhrusheva J
    Hum Psychopharmacol; 2010 Mar; 25(2):133-8. PubMed ID: 20196182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of antipsychotics on weight gain, weight-related hormones and homocysteine in children and adolescents: a 1-year follow-up study.
    Baeza I; Vigo L; de la Serna E; Calvo-Escalona R; Merchán-Naranjo J; Rodríguez-Latorre P; Arango C; Castro-Fornieles J
    Eur Child Adolesc Psychiatry; 2017 Jan; 26(1):35-46. PubMed ID: 27209421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study.
    Lindsay RL; Eugene Arnold L; Aman MG; Vitiello B; Posey DJ; McDougle CJ; Scahill L; Pachler M; McCracken JT; Tierney E; Bozzolo D
    J Intellect Dev Disabil; 2006 Dec; 31(4):204-9. PubMed ID: 17178532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial.
    Aman M; Rettiganti M; Nagaraja HN; Hollway JA; McCracken J; McDougle CJ; Tierney E; Scahill L; Arnold LE; Hellings J; Posey DJ; Swiezy NB; Ghuman J; Grados M; Shah B; Vitiello B
    J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):482-93. PubMed ID: 26262903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia.
    Popovic V; Doknic M; Maric N; Pekic S; Damjanovic A; Miljic D; Popovic S; Miljic N; Djurovic M; Jasovic-Gasic M; Dieguez C; Casanueva FF
    Neuroendocrinology; 2007; 85(4):249-56. PubMed ID: 17570902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone-induced weight gain in referred children with autism spectrum disorders is associated with a common polymorphism in the 5-hydroxytryptamine 2C receptor gene.
    Hoekstra PJ; Troost PW; Lahuis BE; Mulder H; Mulder EJ; Franke B; Buitelaar JK; Anderson GM; Scahill L; Minderaa RB
    J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):473-7. PubMed ID: 21186965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of long-term use of risperidone on body weight of children with an autism spectrum disorder.
    Demb H; Valicenti-McDermott M; Navarro A; Ayoob KT
    J Clin Psychopharmacol; 2011 Oct; 31(5):669-70. PubMed ID: 21881456
    [No Abstract]   [Full Text] [Related]  

  • 11. Risperidone treatment of children with autistic disorder: effectiveness, tolerability, and pharmacokinetic implications.
    Gagliano A; Germanò E; Pustorino G; Impallomeni C; D'Arrigo C; Calamoneri F; Spina E
    J Child Adolesc Psychopharmacol; 2004; 14(1):39-47. PubMed ID: 15142390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.
    Anderson GM; Scahill L; McCracken JT; McDougle CJ; Aman MG; Tierney E; Arnold LE; Martin A; Katsovich L; Posey DJ; Shah B; Vitiello B
    Biol Psychiatry; 2007 Feb; 61(4):545-50. PubMed ID: 16730335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term safety and tolerability of risperidone in children with autism.
    Aman MG; Arnold LE; McDougle CJ; Vitiello B; Scahill L; Davies M; McCracken JT; Tierney E; Nash PL; Posey DJ; Chuang S; Martin A; Shah B; Gonzalez NM; Swiezy NB; Ritz L; Koenig K; McGough J; Ghuman JK; Lindsay RL
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):869-84. PubMed ID: 16379507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-induced weight gain: bipolar disorder and leptin.
    McIntyre RS; Mancini DA; Basile VS; Srinivasan J; Kennedy SH
    J Clin Psychopharmacol; 2003 Aug; 23(4):323-7. PubMed ID: 12920406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone treatment in children and adolescents with autism: short- and long-term safety and effectiveness.
    Malone RP; Maislin G; Choudhury MS; Gifford C; Delaney MA
    J Am Acad Child Adolesc Psychiatry; 2002 Feb; 41(2):140-7. PubMed ID: 11837403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newer antipsychotic drugs and obesity in children and adolescents. How should we assess drug-associated weight gain?
    Vieweg WV; Sood AB; Pandurangi A; Silverman JJ
    Acta Psychiatr Scand; 2005 Mar; 111(3):177-84. PubMed ID: 15701101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term risperidone for pervasive developmental disorder: efficacy, tolerability, and discontinuation.
    Zuddas A; Di Martino A; Muglia P; Cianchetti C
    J Child Adolesc Psychopharmacol; 2000; 10(2):79-90. PubMed ID: 10933118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of risperidone on leptin and insulin in children and adolescents with autistic spectrum disorders.
    Srisawasdi P; Vanwong N; Hongkaew Y; Puangpetch A; Vanavanan S; Intachak B; Ngamsamut N; Limsila P; Sukasem C; Kroll MH
    Clin Biochem; 2017 Aug; 50(12):678-685. PubMed ID: 28167244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone and liver function tests in children and adolescents: a short-term prospective study.
    Erdogan A; Atasoy N; Akkurt H; Ozturk D; Karaahmet E; Yalug I; Yalug K; Ankarali H; Balcioglu I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):849-57. PubMed ID: 18258348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No Differences in Weight Gain Between Risperidone and Aripiprazole in Children and Adolescents After 12 Months.
    Schoemakers RJ; van Kesteren C; van Rosmalen J; Eussen MLJM; Dieleman HG; Beex-Oosterhuis MM
    J Child Adolesc Psychopharmacol; 2019 Apr; 29(3):192-196. PubMed ID: 30672720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.